Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation

Eric Y. Hayden, Prerna Kaur, Thomas L. Williams, Hiroshi Matsui, Syun Ru Yeh, Denis L. Rousseau

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


α-Synuclein (αSyn), which forms amyloid fibrils, is linked to the neuronal pathology of Parkinson's disease, as it is the major fibrillar component of Lewy bodies, the inclusions that are characteristic of the disease. Oligomeric structures, common to many neurodegenerative disease-related proteins, may in fact be the primary toxic species, while the amyloid fibrils exist either as a less toxic dead-end species or even as a beneficial mechanism for clearing damaged proteins. To alter the progression of the aggregation and gain insights into the prefibrillar structures, we determined the effect of heme on αSyn oligomerization by several different techniques, including native (nondenaturing) polyacrylamide gel electrophoresis, thioflavin T fluorescence, transmission electron microscopy, atomic force microscopy, circular dichroism, and membrane permeation using a calcein release assay. During aggregation, heme is able to bind the αSyn in a specific fashion, stabilizing distinct oligomeric conformations and promoting the formation of αSyn into annular structures, thereby delaying and/or inhibiting the fibrillation process. These results indicate that heme may play a regulatory role in the progression of Parkinson's disease; in addition, they provide insights into how the aggregation process may be altered, which may be applicable to the understanding of many neurodegenerative diseases.

Original languageEnglish (US)
Pages (from-to)4599-4610
Number of pages12
Issue number30
StatePublished - Aug 4 2015

ASJC Scopus subject areas

  • Biochemistry


Dive into the research topics of 'Heme Stabilization of α-Synuclein Oligomers during Amyloid Fibril Formation'. Together they form a unique fingerprint.

Cite this